Safety, efficacy and cost of two direct‐acting antiviral regimens: A comparative study in chronic hepatitis C Egyptian patients
AH Ibrahim Mohammed Ebid… - Journal of Clinical …, 2020 - Wiley Online Library
What is known and objective Direct‐acting antivirals (DAAs) have become the most widely
used treatment of chronic hepatitis C infection. Comparative studies on DAAs regimens …
used treatment of chronic hepatitis C infection. Comparative studies on DAAs regimens …
Safety Profile of Ombitasvir/Paritaprevir/Ritonavir and Dasabuvir in Hepatitis C in Romania: an Analysis Conducted in VigiBase®/WHO.
I Cazacu, R Stroe, R Dondera, B Apan… - … of Gastrointestinal & …, 2020 - search.ebscohost.com
Abstract Background & Aims: Due to the increasing number of hepatitis C virus (HCV)-
infected patients being treated with direct antiviral agents (DAAs) in Romania, we aimed to …
infected patients being treated with direct antiviral agents (DAAs) in Romania, we aimed to …